Quantinno Capital Management »

Cytokinetics shares owned by Quantinno Capital Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Quantinno Capital Management from 13F filings

Historical chart of Quantinno Capital Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Quantinno Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Quantinno Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.2M 50k 63.54
2025-09-30 $1.6M 28k 54.96

More positions owned by Quantinno Capital Management

NVIDIA Corporation Put Option (NVDA)
Apple Put Option (AAPL)
Microsoft Corporation Put Option (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Reddit Cl A Put Option (RDDT)
JPMorgan Chase & Co. Put Option (JPM)
Eli Lilly & Co. Put Option (LLY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Quantinno Capital Management

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
State Street Corporation
Deep Track Capital
Geode Capital Management
Susquehanna International
Rtw Investments
Goldman Sachs Group
Polar Capital Holdings
Armistice Capital
Integral Health Asset Management
Citadel Advisors

View all funds holding Cytokinetics